Viral mechanism for engaging lytic cycle promoting host transcription factors

Kaposi's sarcoma-associated herpesvirus (KSHV) is a human tumor virus that is the etiological agent of several AIDS-related malignancies such as B cell lymphomas and Kaposi's sarcoma. KSHV establishes viral latency in most cell types following primary infection but can undergo lytic reactivation. The key viral factor, which drives the lytic cycle of KSHV, is the replication and transcription activator called RTA. We and others have identified the genome-wide targets of RTA and we have also demonstrated the need for the rapid induction of specific host genes concomitantly with the viral genes for efficient lytic reactivation. Uncovering the protein interaction domains of host factors that viral proteins bind to and are crucial for lytic reactivation is important, because they can serve as potential targets for antiviral therapies to abrogate viral transmissions. Our study focuses on one such domain of host factors called the Forkhead-associated (FHA) domain. This is a unique protein-protein interaction domain, which recognizes and binds to specific conserved short linear motifs in proteins. FHA proteins have diverse functions in the regulation of transcription, DNA repair, replication stress response and cell cycle checkpoints. Viral proteins often mimic host protein interaction motifs thereby hijacking host factors and alter cellular functions. Through our unbiased in silico protein sequence screening of KSHV proteins, we identified several viral proteins possessing putative FHA interaction motifs. We hypothesize that these KSHV viral factors can bind to FHA proteins to alter their cellular functions to promote lytic cycle. To test this concept, here we aim to dissect the mechanism of one of these novel viral-FHA protein pairs and determine its role in the regulation of KSHV lytic cycle. We will also evaluate how this finding can be used for an antiviral therapy against KSHV. Project Number: 1R21AI188702-01A1 | Fiscal Year: 2025 | NIH Institute/Center: National Institute of Allergy and Infectious Diseases (NIAID) | Principal Investigator: Bernadett Papp (+1 co-PI) | Institution: UNIVERSITY OF FLORIDA, GAINESVILLE, FL | Award Amount: $402,150 | Activity Code: R21 | Study Section: Viral Pathogenesis and Immunity Study Section [VPI] View on NIH RePORTER: https://reporter.nih.gov/project-details/1R21AI18870201A1